Literature DB >> 23297552

Randomized, double-blind, parallel-controlled clinical trial on correspondence of prescriptions and traditional Chinese medicine syndrome of ischemic stroke.

Ying Gao1, Haizhen Zhong, Bin Ma, Yue Huang.   

Abstract

OBJECTIVE: To investigate the effect of correspondence of prescriptions and the traditional Chinese medicine (TCM) syndrome of ischemic stroke.
METHODS: Based on standard syndrome diagnosis and a series of effective formulas, a randomized, double-blind, parallel-controlled clinical trial on correspondence of prescriptions and the TCM syndrome of ischemic stroke was conducted. The formulas were dynamically changed according to the patient's TCM syndrome.
RESULTS: The treatment was composed of a series of formulas changed daily according to the TCM syndrome. Treatments which were composed of a series of formulas had similar short-term (1 month after onset) effects in improving mild and moderate neurological deficits compared with treatments composed of only one formula. However, patients treated with a series of formulas showed improved subjective symptoms in the short-term and a decreased risk of stroke recurrence within three months after onset.
CONCLUSION: Complete (series of formulas) and incomplete (only one formula) correspondence of prescriptions and TCM syndrome have similar effects on the central clinical manifestation of ischemic stroke, such as neurological deficit and activities in daily living. However, they have significant differences regarding individual dysfunctions, such as subjective symptoms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23297552     DOI: 10.1016/s0254-6272(13)60034-5

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  6 in total

Review 1.  Adaption and application of the four phase trials to traditional chinese medicines.

Authors:  M Y Di; J L Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

2.  Neuroprotective effect of a novel Chinese herbal decoction on cultured neurons and cerebral ischemic rats.

Authors:  Fanny Chui-Fun Ip; Yu-Ming Zhao; Kim-Wan Chan; Elaine Yee-Ling Cheng; Estella Pui-Sze Tong; Oormila Chandrashekar; Guang-Miao Fu; Zhong-Zhen Zhao; Nancy Yuk-Yu Ip
Journal:  BMC Complement Altern Med       Date:  2016-11-04       Impact factor: 3.659

3.  Integrated Modules Analysis to Explore the Molecular Mechanisms of Phlegm-Stasis Cementation Syndrome with Ischemic Heart Disease.

Authors:  Wei-Ming Xu; Kuo Yang; Li-Jie Jiang; Jing-Qing Hu; Xue-Zhong Zhou
Journal:  Front Physiol       Date:  2018-01-22       Impact factor: 4.566

4.  A new prognostic scale for the early prediction of ischemic stroke recovery mainly based on traditional Chinese medicine symptoms and NIHSS score: a retrospective cohort study.

Authors:  Ke-Gang Cao; Cai-Hong Fu; Huan-Qin Li; Xi-Yan Xin; Ying Gao
Journal:  BMC Complement Altern Med       Date:  2015-11-16       Impact factor: 3.659

5.  Decreased stroke risk with combined traditional Chinese and western medicine in patients with ischemic heart disease: A real-world evidence.

Authors:  Yu-Chen Cheng; Cheng-Nan Lu; Wen-Long Hu; Chung Y Hsu; Yuan-Chih Su; Yu-Chiang Hung
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

6.  Effects of Xingnaojing on serum high-sensitivity C-reactive protein and neuron-specific enolase in patients with acute cerebral hemorrhage: A protocol of systematic review and meta-analysis.

Authors:  Zhe-Ren Zhou; Yun-Hua Zhao; Rong Sun; Yu-Rong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.